Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0001104659-19-070227

Options or other derivatives

  • CEO and CFO acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SHALLCROSS STEVEN A · CEO and CFO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-04 Grant or award : show line 1 in the form Stock Options +450,000 450,000 D
Loading xslF345X03/tm1923941d2_form4.xml…